2025. Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study. Asian Journal of Pharmaceutical and Health Sciences. 15, 3 (Sep. 2025), 3114–3121. DOI:https://doi.org/10.5530/ajphs.2025.15.83.